Han Chong Toh/LinkedIn
Jun 4, 2025, 06:08
Han Chong Toh Recaps ASCO 2025 Highlights in Immunotherapy and AI
Han Chong Toh, Deputy Chief Executive Officer at National Cancer Centre Singapore, shared a post on LinkedIn:
“ASCO2025 comes to a rousing close today *big AI sessions* what an electric packed plenary session that showcased the superpower of immune checkpoint inhibitor therapy across colon, gastric (Yelena Janjigian quoted Taylor Swift in the matterhorn trial), head and neck cancer.
So special to then have the checkpoints perform in the evening for a Society for Immunotherapy of Cancer (SITC) fundraiser at buddy guy legends a band of immunotherapy giants Lisa Butterfield, Jedd Wolchok, Thomas Gajewski et al led by nobel prize winner Jim Allison.
Allison the checkpoints and those in the house like Bernard A. Fox, Lillian Siu etc. blazed the trail in cancer immunotherapy, improving the lives of so many cancer patients. congrats to my Duke-NUS Medical School med student Junzhe (Jacky) Zhao for an outstanding poster of our liver cancer 3D organoid work and how liver intrinsic innate immunity could blunt immune checkpoint inhibitor therapy.”
More posts featuring ASCO25.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 19:30
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47
Jun 26, 2025, 17:29